Simultaneously, engineered exosomes can deliver tumor-targeting molecules, such as TNF-related apoptosis-inducing ligand (TRAIL), which induces apoptosis in cancer cells without affecting healthy tissue (Zhang X. et al., 2024). This evidence concerns the gene TNFSF10 and neoplasm.